StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
Publishing Date
2021 - 03 - 16
9
Sector
Health technology
9
Tags
Acquisition
8
Acquisition corp
5
Alliances
4
Announces collaboration
3
Application
3
Approval
3
Biomidwest
3
Bioscience
5
Biotech-beach
6
Brands
6
Cancer
4
Charging
3
China
3
Collaboration
5
Commercialization
5
Conference
27
Covid
9
Designation
3
Diagnostic
3
Diagnostics
3
Disease
4
Distribution
4
Drug
7
Earnings
3
Energy
15
Ev
3
Events
4
Financial results
36
Food
4
Funding
4
Genetown
3
Germany
3
Growing
3
Growth
13
Health
5
Iot
5
License
3
Life science
4
Liver
4
Mobile
3
Money
3
N/a
254
Offering
19
Partnership
5
Pharm-country
5
Pharma
3
Pharmaceutical
8
Phase 1
4
Phase 2
8
Phase 3
9
Positive
4
Product-news
3
Publication
5
Renewable
5
Research
6
Results
55
Technology
4
Test
5
Therapy
5
Trial
9
Entities
Anavex life sciences corp.
1
Chinook therapeutics, inc.
1
Eli lilly and company
1
Fibrogen, inc
1
Galmed pharmaceuticals ltd.
1
Histogen inc.
1
Johnson & johnson
1
Oramed pharmaceuticals inc.
1
Pliant therapeutics, inc.
1
Symbols
AVXL
1
FGEN
1
GLMD
1
HSTO
1
JNJ
1
KDNY
1
LLY
1
ORMP
1
PLRX
1
Exchanges
Nasdaq
7
Nyse
2
Crawled Date
2022 - 06 - 13
6
2022 - 06 - 07
6
2022 - 05 - 24
6
2022 - 05 - 23
8
2022 - 04 - 06
6
2022 - 03 - 26
6
2022 - 03 - 07
7
2022 - 01 - 04
8
2021 - 12 - 14
9
2021 - 12 - 13
7
2021 - 12 - 09
6
2021 - 12 - 06
10
2021 - 11 - 15
8
2021 - 10 - 25
6
2021 - 10 - 18
7
2021 - 09 - 29
8
2021 - 09 - 27
6
2021 - 09 - 16
6
2021 - 09 - 15
9
2021 - 08 - 31
6
2021 - 08 - 16
10
2021 - 08 - 05
6
2021 - 07 - 06
6
2021 - 06 - 28
9
2021 - 06 - 23
6
2021 - 06 - 17
6
2021 - 06 - 16
8
2021 - 06 - 11
9
2021 - 06 - 10
6
2021 - 06 - 08
8
2021 - 06 - 07
8
2021 - 06 - 04
8
2021 - 06 - 03
6
2021 - 06 - 01
6
2021 - 05 - 25
6
2021 - 05 - 19
8
2021 - 05 - 03
11
2021 - 04 - 23
7
2021 - 04 - 13
7
2021 - 04 - 12
8
2021 - 03 - 23
6
2021 - 03 - 16
9
2021 - 03 - 15
8
2021 - 03 - 10
6
2021 - 02 - 25
7
2021 - 02 - 22
5
2021 - 02 - 12
5
2021 - 01 - 25
5
2021 - 01 - 19
5
2020 - 12 - 23
6
2020 - 12 - 22
5
2020 - 12 - 21
10
2020 - 12 - 17
7
2020 - 12 - 15
7
2020 - 12 - 10
9
2020 - 12 - 09
8
2020 - 12 - 07
10
2020 - 12 - 03
15
2020 - 12 - 02
8
2020 - 12 - 01
22
Crawled Time
11:00
1
12:00
3
13:00
2
14:00
2
15:00
1
Source
www.biospace.com
8
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Phase 3
crawled date :
2021 - 03 - 16
save search
Histogen and Amerimmune Announce First Patient Dosed in Phase 1 Study of Emricasan in Symptomatic COVID-19 PatientsTopline Results Expected in the Second Quarter of 2021
Published:
2021-03-16
(Crawled : 15:00)
- biospace.com/
HSTO
1 d
|
$0.5
67.46%
530
|
Health Technology
|
-65.28%
|
O:
1.39%
H:
0.0%
C:
-4.11%
covid
phase 1
results
phase 3
phase 2
Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner
Published:
2021-03-16
(Crawled : 14:00)
- biospace.com/
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-67.25%
|
O:
1.12%
H:
2.4%
C:
-0.41%
phase 1
phase 3
phase 2
Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 ALIGN Study of Atrasentan for Patients with IgA Nephropathy
Published:
2021-03-16
(Crawled : 14:00)
- biospace.com/
KDNY
|
$40.39
0.22%
-0.17%
0
|
Health Technology
|
116.92%
|
O:
0.05%
H:
0.0%
C:
-7.25%
nephropathy
phase 3
enroll
Galmed Pharmaceuticals Announces Dosing of First Subject in First in Human Phase 1 Trial of Amilo-5MER
Published:
2021-03-16
(Crawled : 13:00)
- biospace.com/
GLMD
|
$0.3787
-0.41%
18K
|
Health Technology
|
-89.72%
|
O:
3.89%
H:
2.67%
C:
-6.15%
phase 1
trial
phase 3
phase 2
Oramed Reaches 25% Randomization in World's First Phase 3 Oral Insulin Study Conducted Under FDA Approved Protocol
Published:
2021-03-16
(Crawled : 13:00)
- biospace.com/
ORMP
A
|
$2.265
2.96%
2.87%
110K
|
Health Technology
|
-75.51%
|
O:
1.29%
H:
4.9%
C:
2.66%
fda
insulin
phase 3
fda approval
New Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Achieved Complete Skin Clearance and Favorable Joint Efficacy in Adult Patients with Active Psoriatic Arthritis (PsA) Through Two Years
Published:
2021-03-16
(Crawled : 12:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.8%
|
O:
0.02%
H:
0.76%
C:
0.57%
phase 3
skin
clearance
FibroGen Initiates LELANTOS-2 – Second Phase 3 Clinical Study of Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy
Published:
2021-03-16
(Crawled : 12:00)
- biospace.com/
FGEN
|
$1.15
-1.71%
-1.74%
1.3M
|
Health Technology
|
-96.63%
|
O:
-1.32%
H:
3.27%
C:
-0.45%
treatment
phase 3
duchenne
Anavex Life Sciences Reports ANAVEX®2-73 (blarcamesine) featured as a Disease-Modifying Small Molecule in Phase 3 Clinical Trials in a New Publication in Medical Journal titled “Future Avenues for Alzheimer’s Disease Detection and Therapy”
Published:
2021-03-16
(Crawled : 12:00)
- biospace.com/
AVXL
|
News
|
$3.8
0.0%
2.1M
|
Health Technology
|
-74.49%
|
O:
4.25%
H:
6.08%
C:
4.4%
disease
alzheimer
clinical trials
therapy
life science
phase 3
trial
anavex®2-73
anavex
alzheimer’s
alzheimer's disease
alzheimer's
Lilly's Mirikizumab Helps Patients Achieve Clinical Remission and Improves Symptoms in Adults with Ulcerative Colitis in 12-Week Phase 3 Induction Study
Published:
2021-03-16
(Crawled : 11:00)
- prnewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
283.97%
|
O:
1.26%
H:
0.04%
C:
-0.33%
phase 3
ulcerative colitis
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.